13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001802451
Total reported value
$298.5M
$298.5M
587 檔
34.4%
As reported in its official Q2 2024 Form 13F filing, HighMark Wealth Management LLC's tracked investment portfolio stood at $298.5M with 587 total positions.
During Q2 2024, HighMark Wealth Management LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
In terms of portfolio concentration, the top 5 core holdings (including IVV, EFV, IWM) accounted for 34.4% of total reported equity market value during Q2 2024.
Showing top 200 holdings (of 587 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | IVV | Ishares Core S&p 500 ETF | ETF-Large Cap & Growth | 36.31% | -3.44% | +0.83% | |
| 2 | EFV | Ishares Msci Eafe Value ETF | ETF-Other | 8.42% | -1.56% | -3.60% | |
| 3 | IWM | Ishares Russell 2000 ETF | ETF-Small Cap | 7.39% | -0.38% | -2.54% | |
| 4 | IJR | Ishares Core S&p Small-cap E | ETF-Small Cap | 5.44% | -0.11% | +2.86% | |
| 5 | IUSV | Ishares Core S&p U.s. Value | ETF-Other | 4.24% | -0.55% | -1.15% | |
| 6 | WFC | Wells Fargo & Co | Stock-Financials | 2.67% | -0.32% | +0.01% | |
| 7 | IJH | Ishares Core S&p Midcap ETF | ETF-Other | 2.58% | -0.05% | +2.36% | |
| 8 | DWAS | Invesco Dorsey Wright Smallc | ETF-Other | 2.50% | +0.11% | -1.43% | |
| 9 | PFMTUSD | Performant Financial CORP | Stock-Other | 1.37% | — | +8.27% | |
| 10 | LLY | Eli Lilly & Co | Stock-Healthcare | 1.21% | +0.05% | +0.32% | |
| 11 | ATRC | Atricure Inc | Stock-Other | 0.96% | -0.19% | +664.11% | |
| 12 | IVE | Ishares S&p 500 Value ETF | ETF-Large Cap & Growth | 0.90% | -0.04% | +0.69% | |
| 13 | AAPL | Apple Inc | Stock-Tech | 0.88% | -0.07% | +45.75% | |
| 14 | MSFT | Microsoft CORP | Stock-Tech | 0.86% | -0.09% | +1.36% | |
| 15 | NVDA | Nvidia CORP | Stock-Tech | 0.80% | -0.12% | +976.52% | |
| 16 | NEO | Neogenomics Inc | Stock-Healthcare | 0.77% | +1.24% | +2993.33% | |
| 17 | ATEC | Alphatec Holdings Inc | Stock-Other | 0.68% | -0.08% | +87.11% | |
| 18 | USB | US Bancorp | Stock-Financials | 0.68% | -0.02% | +1.33% | |
| 19 | TRV | Travelers Cos Inc/the | Stock-Financials | 0.67% | -0.04% | +87.02% | |
| 20 | TNDM | Tandem Diabetes Care Inc | Stock-Other | 0.66% | -0.10% | — | |
| 21 | AGG | Ishares Core U.s. Aggregate | ETF-Other | 0.65% | -0.06% | +8.67% | |
| 22 | TLT | Ishares 20+ Year Treasury Bd | ETF-Gov Bonds | 0.64% | -0.21% | +9.56% | |
| 23 | MMM | 3m Co | Stock-Industrials | 0.56% | -0.05% | +20.30% | |
| 24 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 0.54% | +0.18% | +16.15% | |
| 25 | SPEM | State Street Sp Ptf Em ETF | ETF-Other | 0.51% | -0.06% | -1.73% | |
| 26 | PG | Procter & Gamble Co/the | Stock-Consumer Staples | 0.51% | -0.04% | +45.61% | |
| 27 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 0.51% | -3.83% | EXIT | |
| 28 | IWN | Ishares Russell 2000 Value E | ETF-Small Cap | 0.50% | +0.02% | +5.87% | |
| 29 | VOO | Vanguard S&p 500 ETF | ETF-Large Cap & Growth | 0.47% | -0.43% | — | |
| 30 | PLRX | Pliant Therapeutics Inc | Stock-Other | 0.44% | -0.03% | +58.82% | |
| 31 | FNAUSD | Paragon 28 Inc | Stock-Other | 0.40% | — | — | |
| 32 | IJJ | Ishares S&p Mid-cap 400 Valu | ETF-Other | 0.38% | -0.01% | -3.27% | |
| 33 | VTI | Vanguard Total Stock Mkt ETF | ETF-Other | 0.38% | -0.01% | — | |
| 34 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 0.38% | -0.03% | -6.89% | |
| 35 | XEL | Xcel Energy Inc | Stock-Utilities | 0.37% | -0.07% | +1.15% | |
| 36 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 0.36% | — | -1.97% | |
| 37 | SHY | Ishares 1-3 Year Treasury Bo | ETF-Gov Bonds | 0.36% | -0.01% | -6.27% | |
| 38 | IJS | Ishares S&p Small-cap 600 Va | ETF-Other | 0.35% | — | -3.32% | |
| 39 | AUPH | Aurinia Pharmaceuticals Inc | Stock-Other | 0.31% | -0.01% | +21.28% | |
| 40 | ECL | Ecolab Inc | Stock-Materials | 0.30% | -0.03% | +1.82% | |
| 41 | ABT | Abbott Laboratories | Stock-Healthcare | 0.26% | -0.05% | — | |
| 42 | VV | Vanguard Large-cap ETF | ETF-Other | 0.25% | -0.02% | — | |
| 43 | OEF | Ishares S&p 100 ETF | ETF-Other | 0.24% | -0.01% | -5.00% | |
| 44 | HSBC | Hsbc Holdings Plc-spons Adr | Stock-Financials | 0.24% | -0.01% | +0.02% | |
| 45 | XOM | Exxon Mobil CORP | Stock-Energy | 0.21% | -0.08% | +2.52% | |
| 46 | DXCM | Dexcom Inc | Stock-Healthcare | 0.21% | -0.03% | +0.53% | |
| 47 | PRTA | Prothena Corporation plc | Stock-Other | 0.20% | — | — | |
| 48 | COST | Costco Wholesale CORP | Stock-Consumer Staples | 0.20% | -0.05% | — | |
| 49 | KRMD | Koru Medical Systems Inc | Stock-Other | 0.19% | -0.04% | — | |
| 50 | PRLB | Proto Labs Inc | Stock-Other | 0.18% | — | — |
According to official SEC Form 13F filings, HighMark Wealth Management LLC reported a total U.S. public equity portfolio value of $298.5M across 587 disclosed positions in Q2 2024.
During Q2 2024, HighMark Wealth Management LLC's top holdings by market value included IVV (36.3%)、EFV (8.4%)、IWM (7.4%). The largest single position, IVV, represented 36.3% of total portfolio value.
In Q2 2024, HighMark Wealth Management LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.